Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

Delayed Quote. Delayed  - 04/29 09:59:59 pm
2.95 USD   -2.96%
04/27 Geron Announces Conference Call to Discuss First Quarter 2016 Fin..
04/20 Geron Announces Two Imetelstat Poster Presentations at the Americ..
04/06 GERON : to Present at the Needham Healthcare Conference
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
3.21(c) 3.11(c) 3.09(c) 3.04(c) 2.95(c) Last
1 097 330 2 061 597 1 066 892 1 530 320 1 816 356 Volume
-1.83% -3.12% -0.64% -1.62% -2.96% Change
More quotes
Financials ($)
Sales 2016 4,87 M
EBIT 2016 -36,9 M
Net income 2016 -27,2 M
Debt 2016 -
Yield 2016 -
Sales 2017 36,8 M
EBIT 2017 -4,16 M
Net income 2017 4,03 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 99,2x
Capi. / Sales 2017 13,1x
Capitalization 483 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
04/27 Geron Announces Conference Call to Discuss First Quarter 2016 Financial Resul..
04/20 Geron Announces Two Imetelstat Poster Presentations at the American Associati..
04/06 GERON : to Present at the Needham Healthcare Conference
04/05 Geron to Present at the Needham Healthcare Conference
03/30 GERON CORPORATION : Why Investors Are So Bullish on This Small Biotech
03/17 Geron Announces Presentations at American Association of Cancer Research Annu..
03/02 GERON CORPORATION : (NASDAQ: GERN) Favorable Financial Results and Positive Guid..
02/26 GERON : reports 4Q loss
More news
Sector news : Bio Therapeutic Drugs
04:29pDJMedivation Rejects Sanofi's $9.3 Billion Takeover Bid--Update
04:15pDJMedivation Rejects Sanofi's Takeover Bid
04:01pDJMedivation Rejects Sanofi's $9.3 Billion Takeover Bid
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/21 An Analysis Of The iShares Micro-Cap ETF
02/25 Geron's (GERN) CEO John Scarlett on Q4 2015 Results - Earnings Call Transcrip..
02/25 Geron +3% after in-line Q4 loss
02/25 Geron EPS in-line, misses on revenue
02/24 Notable earnings after Thursday?s close


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions